TRDA
Entrada Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$12.69
-0.29 ▼ -2.23%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$12.69
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -3.47 | Insider Own | 43.57% | Shs Outstand | 0.04B | Perf Week | 0.87% |
| Market Cap | 0.49B | Forward P/E | - | EPS next Y | 5.8% | Insider Trans | -1.43% | Shs Float | 0.02B | Perf Month | 14.63% |
| Enterprise Value | 0.24B | PEG | - | EPS next Q | -1.02 | Inst Own | 45.92% | Short Float | 3.81% | Perf Quarter | 19.83% |
| Income | -0.14B | P/S | 19.11 | EPS this Y | -12.8% | Inst Trans | -12.88% | Short Ratio | 3.68 | Perf Half Y | 138.09% |
| Sales | 0.03B | P/B | 1.59 | EPS next 5Y | -0.17% | ROA | -31.81% | Short Interest | 0.82M | Perf YTD | 23.44% |
| Book/sh | 8 | P/C | 1.64 | EPS past 3/5Y | -4.74% -32.56% | ROE | -39.13% | 52W High | -7.07% ($13.65) | Perf Year | 17.28% |
| Cash/sh | 7.74 | P/FCF | - | Sales past 3/5Y | - | ROIC | -40.73% | 52W Low | 157.4% ($4.93) | Perf 3Y | -2.76% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -274.08% | Gross Margin | 83.75% | Volatility(W/M) | 7% 7.47% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 9.46 | Sales Y/Y TTM | -87.94% | Oper. Margin | -613.66% | ATR (14) | 0.88 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 12.53 | EPS Q/Q | -3679.47% | Profit Margin | -565.48% | RSI (14) | 56.86 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 12.53 | Sales Q/Q | -96.53% | SMA20 | 5.57% ($12.02) | Beta | -0.15 | Target Price | $20 |
| Payout | - | Debt/Eq | 0.17 | Earnings | 2000000 | SMA50 | 12.26% ($11.3) | Rel Volume | 0.61 | Prev Close | $12.98 |
| Employees | 152 | LT Debt/Eq | 0.15 | EPS/Sales Surpr. | 18.28% -82.47% | SMA200 | 54.46% ($8.22) | Avg Volume(3M) | 0.22M | Price | $12.69 |
| IPO | 2021/10/29 | Option/Short | Yes/Yes | Trades | 2816 | Volume | 137,222 | Change | -2.23% |
뉴스 로딩 중...